Oral Antiviral Therapy Utilization Among Adults with Recent COVID-19 in the United States.

A minority of increased-risk US residents have accessed early therapy for COVID-19 despite being made available without cost. Responses suggest that efforts to improve patient and provider knowledge could improve utilization to mitigate future COVID-19 hospitalizations.